Trius Therapeutics to Present at JMP Securities Research Conference

SAN DIEGO, May 10, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide a corporate presentation on Wednesday, May 11 at 11:30 a.m. at the Tenth Annual JMP Securities Research Conference. The presentation will take place in San Francisco, California at the Ritz Carlton in Salon II.

MORE ON THIS TOPIC